广康生化：深圳市华拓至远投资企业（有限合伙）等股东合计减持222万股

Group 1 - Company Guangkang Biochemical announced a share reduction plan by specific shareholders, allowing them to reduce up to 2.22 million shares, which is 3% of the total share capital, from June 9, 2025, to September 8, 2025 [1] - The shareholders have completed their reduction plan, having sold a total of 2.22 million shares, representing 3% of the company's total share capital [1] - For the year 2024, Guangkang Biochemical's revenue composition is heavily weighted towards pesticides, accounting for 99.84% of total revenue, with other businesses making up only 0.16% [1] Group 2 - The current market capitalization of Guangkang Biochemical is 3.1 billion yuan [2]